Risk of falls seen with newer antiandrogens for prostate cancerJune 9, 2023Genitourinary CancerProstate Cancer
ER+/HER2– breast cancer: Is first or second line CDK4/6 inhibitor therapy better?June 7, 2023Breast Cancer
Ovarian cancer: Sequencing strategy identifies biomarker that could guide treatmentJune 6, 2023Oncology
Metronomic chemotherapy performs well in second-line head and neck cancerJune 6, 2023Head & Neck/Thyroid Cancers
